2020 Postcard from Palm Springs
Highlights from the 2020 CHDI HD Therapeutics Conference are now here! This year’s Postcard covers HTT-lowering therapeutics, including an
Read more
Navigator Research Program
THE 2024 COMPETITION IS CLOSED
Navigator Research Program Overview
Our mission at HSC is to improve the quality of life for those affected by Huntington disease. One of the ways that we address our mission is by investing in promising research.
The Navigator Research Program has been providing funding to support HD researchers since 2003 with awards up to $75,000/year for 1-2 years.
Goals of the Navigator Research Program include:
- Funding for Canadian scientific research of direct and immediate relevance to Huntington Disease
- To provide a platform for the future recruitment of outstanding investigators to HD research
- To facilitate research collaboration nationally and internationally
- To support research which is relevant to other neurodegenerative disorders as well as HD
Click here for the Navigator Research Program – Terms of Reference
Click here for the Navigator Research Program – Application for Funding
Click here for the 2024 Research Competition Letter of Intent
2024 RECIPIENT – CLICK HERE FOR PAST RECIPIENTS
HSC Funds a New Navigator Research Project: HSC has awarded the Navigator Award to Dr. Shaun Sanders (University of Guelph – lead investigator), Dr. Melanie Alpaugh (University of Guelph – co-investigator), and Dr. Dale Martin (University of Waterloo – co-investigator). The title of their research project is DLK as a novel therapeutic target to treat Huntington disease.
DLK activates death signals in HD; however, no studies have investigated if stopping the action of DLK could be beneficial in HD. The HSC Navigator Award funding ($75,000 per year for two years) provides the opportunity to do so.